BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31242404)

  • 21. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ.
    Zhang X; Shi G; Gao F; Liu P; Wang H; Tan X
    Oncol Rep; 2019 Apr; 41(4):2117-2125. PubMed ID: 30720116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
    Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
    Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arrangement of expression and distribution of tight junction protein claudin-1 in cell dissociation of pancreatic cancer cells.
    Tan X; Egami H; Ishikawa S; Kurizaki T; Nakagawa M; Hirota M; Ogawa M
    Int J Oncol; 2004 Dec; 25(6):1567-74. PubMed ID: 15547692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTK6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling.
    Ono H; Basson MD; Ito H
    PLoS One; 2014; 9(5):e96060. PubMed ID: 24788754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway.
    Han HB; Gu J; Ji DB; Li ZW; Zhang Y; Zhao W; Wang LM; Zhang ZQ
    World J Gastroenterol; 2014 Dec; 20(48):18260-70. PubMed ID: 25561793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study.
    Dai H; Chen H; Liu W; You Y; Tan J; Yang A; Lai X; Bie P
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2107-17. PubMed ID: 27444299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis.
    Yan Z; Ohuchida K; Fei S; Zheng B; Guan W; Feng H; Kibe S; Ando Y; Koikawa K; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Hashizume M; Nakamura M
    J Exp Clin Cancer Res; 2019 May; 38(1):221. PubMed ID: 31133044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells.
    Veit C; Genze F; Menke A; Hoeffert S; Gress TM; Gierschik P; Giehl K
    Cancer Res; 2004 Aug; 64(15):5291-300. PubMed ID: 15289335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.
    Ruan S; Lin M; Zhu Y; Lum L; Thakur A; Jin R; Shao W; Zhang Y; Hu Y; Huang S; Hurt EM; Chang AE; Wicha MS; Li Q
    Cancer Res; 2020 Feb; 80(4):771-783. PubMed ID: 31843981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basement membrane proteins play an important role in the invasive processes of human pancreatic cancer cells.
    Sawai H; Okada Y; Funahashi H; Takahashi H; Matsuo Y; Yasuda A; Ochi N; Takeyama H; Manabe T
    J Surg Res; 2008 Jan; 144(1):117-23. PubMed ID: 17688882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ITGA6 and RPSA synergistically promote pancreatic cancer invasion and metastasis via PI3K and MAPK signaling pathways.
    Wu Y; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu M; Jin H
    Exp Cell Res; 2019 Jun; 379(1):30-47. PubMed ID: 30894280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
    He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
    Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
    Camp ER; Yang A; Gray MJ; Fan F; Hamilton SR; Evans DB; Hooper AT; Pereira DS; Hicklin DJ; Ellis LM
    Cancer; 2007 Mar; 109(6):1030-9. PubMed ID: 17311308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A small molecule induces integrin β4 nuclear translocation and apoptosis selectively in cancer cells with high expression of integrin β4.
    Liu SY; Ge D; Chen LN; Zhao J; Su L; Zhang SL; Miao JY; Zhao BX
    Oncotarget; 2016 Mar; 7(13):16282-96. PubMed ID: 26918348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between the expression of extracellular signal-regulated kinase 1/2 and the dissociation of pancreatic cancer cells: Involvement of ERK1/2 in the dissociation status of cancer cells.
    Tan X; Egami H; Ishikawa S; Kurizaki T; Tamori Y; Takai E; Hirota M; Ogawa M
    Int J Oncol; 2004 Apr; 24(4):815-20. PubMed ID: 15010817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The integrin alpha5beta1 regulates alphavbeta3-mediated extracellular signal-regulated kinase activation.
    Ly DP; Corbett SA
    J Surg Res; 2005 Feb; 123(2):200-5. PubMed ID: 15680379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
    Xu DF; Wang LS; Zhou JH
    Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Butyrate inhibits pancreatic cancer invasion.
    Farrow B; Rychahou P; O'Connor KL; Evers BM
    J Gastrointest Surg; 2003 Nov; 7(7):864-70. PubMed ID: 14592659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Integrin β4 in Lung Endothelial Cell Inflammatory Responses to Mechanical Stress.
    Chen W; Epshtein Y; Ni X; Dull RO; Cress AE; Garcia JG; Jacobson JR
    Sci Rep; 2015 Nov; 5():16529. PubMed ID: 26572585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer.
    Ding XZ; Tong WG; Adrian TE
    Oncology; 2003; 65(4):285-94. PubMed ID: 14707447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.